|
Volumn 293, Issue 21, 2005, Pages
|
Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial.
a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARDIOPLEGIC AGENT;
GLUCOSE;
GLUCOSE INSULIN POTASSIUM CARDIOPLEGIC SOLUTION;
GLUCOSE-INSULIN-POTASSIUM CARDIOPLEGIC SOLUTION;
INSULIN;
POTASSIUM;
ANTICOAGULANT AGENT;
HEPARIN;
DIABETES MELLITUS;
GLUCOSE BLOOD LEVEL;
HEART INFARCTION;
HUMAN;
MORTALITY;
NOTE;
BLOOD GLUCOSE;
CARDIOPLEGIC SOLUTIONS;
DIABETES MELLITUS;
GLUCOSE;
HUMANS;
INSULIN;
MYOCARDIAL INFARCTION;
POTASSIUM;
ANTICOAGULANTS;
HEPARIN;
|
EID: 19644399045
PISSN: None
EISSN: 15383598
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (9)
|
References (0)
|